mTOR, autofagia y cáncer: ad portas del nuevo decreto de la Ley Ricarte Soto

Arancibia, Javiera; Labbé, Tomas P; Ríos, Juvenal A

mTOR, autofagia y cáncer: ad portas del nuevo decreto de la Ley Ricarte Soto / mTOR inhibitors, autophagia and Cancer: looking forward to a universal financial coverage

Arancibia, Javiera; Labbé, Tomas P; Ríos, Juvenal A.

Arancibia, Javiera; Universidad de Santiago. Facultad de Cs. Médicas. Escuela de Medicina. CL
Labbé, Tomas P; Universidad de Santiago. Facultad de Cs. Médicas. Escuela de Medicina. CL
Ríos, Juvenal A; Universidad de Santiago. Facultad de Cs. Médicas. Escuela de Medicina. CL

Rev. méd. Chile ; 147(5): 674-676, mayo 2019.

Article in Spanish | LILACS | ID: biblio-1014279

Subject(s)

Humans; Autophagy/physiology; TOR Serine-Threonine Kinases/antagonists & inhibitors; TOR Serine-Threonine Kinases/metabolism; Neoplasms/drug therapy; Antineoplastic Agents/therapeutic use; Sirolimus/analogs & derivatives; Sirolimus/economics; Sirolimus/therapeutic use; Everolimus/economics; Everolimus/therapeutic use; Neoplasms/metabolism; Antineoplastic Agents/economics

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Autophagy / TOR Serine-Threonine Kinases / Neoplasms / Antineoplastic Agents Type of study: Health economic evaluation Limits: Humans Language: Spanish Journal: Rev. méd. Chile Journal subject: Medicine Year: 2019 Type: Article Affiliation country: Chile Institution/Affiliation country: Universidad de Santiago/CL

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google